Cargando…
Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
BACKGROUND: Familial chylomicronemia syndrome (FCS) is a rare lipid disease caused by complete lipoprotein lipase (LPL) deficiency resulting in fasting chylomicronemia and severe hypertriglyceridemia. Inhibition of diacylglycerol acyltransferase 1 (DGAT1), which mediates chylomicron triglyceride (TG...
Autores principales: | Meyers, Charles Daniel, Tremblay, Karine, Amer, Ahmed, Chen, Jin, Jiang, Liewen, Gaudet, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337059/ https://www.ncbi.nlm.nih.gov/pubmed/25889044 http://dx.doi.org/10.1186/s12944-015-0006-5 |
Ejemplares similares
-
Dissection of Clinical and Gene Expression Signatures of Familial versus Multifactorial Chylomicronemia
por: Tremblay, Karine, et al.
Publicado: (2020) -
Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics
por: Björnson, E., et al.
Publicado: (2019) -
The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels
por: Drouin-Chartier, Jean-Philippe, et al.
Publicado: (2017) -
ApoB48 as an Efficient Regulator of Intestinal Lipid Transport
por: Lo, Chunmin C., et al.
Publicado: (2020) -
The burden of familial chylomicronemia syndrome in Canadian patients
por: Gaudet, Daniel, et al.
Publicado: (2020)